Copyright Reports & Markets. All rights reserved.

Global Fragment-based Drug Discovery Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Fragment Screening
      • 1.4.3 Fragment Optimization
    • 1.5 Market by Application
      • 1.5.1 Global Fragment-based Drug Discovery Market Share by Application (2014-2025)
      • 1.5.2 Biopharmaceutical Companies
      • 1.5.3 CROs
      • 1.5.4 Academic and Research Institutions
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Fragment-based Drug Discovery Market Size
    • 2.2 Fragment-based Drug Discovery Growth Trends by Regions
      • 2.2.1 Fragment-based Drug Discovery Market Size by Regions (2014-2025)
      • 2.2.2 Fragment-based Drug Discovery Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Fragment-based Drug Discovery Market Size by Manufacturers
      • 3.1.1 Global Fragment-based Drug Discovery Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI)
    • 3.2 Fragment-based Drug Discovery Key Players Head office and Area Served
    • 3.3 Key Players Fragment-based Drug Discovery Product/Solution/Service
    • 3.4 Date of Enter into Fragment-based Drug Discovery Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Fragment-based Drug Discovery Market Size by Type (2014-2019)
    • 4.2 Global Fragment-based Drug Discovery Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Fragment-based Drug Discovery Market Size (2014-2019)
    • 5.2 Fragment-based Drug Discovery Key Players in United States
    • 5.3 United States Fragment-based Drug Discovery Market Size by Type
    • 5.4 United States Fragment-based Drug Discovery Market Size by Application

    6 Europe

    • 6.1 Europe Fragment-based Drug Discovery Market Size (2014-2019)
    • 6.2 Fragment-based Drug Discovery Key Players in Europe
    • 6.3 Europe Fragment-based Drug Discovery Market Size by Type
    • 6.4 Europe Fragment-based Drug Discovery Market Size by Application

    7 China

    • 7.1 China Fragment-based Drug Discovery Market Size (2014-2019)
    • 7.2 Fragment-based Drug Discovery Key Players in China
    • 7.3 China Fragment-based Drug Discovery Market Size by Type
    • 7.4 China Fragment-based Drug Discovery Market Size by Application

    8 Japan

    • 8.1 Japan Fragment-based Drug Discovery Market Size (2014-2019)
    • 8.2 Fragment-based Drug Discovery Key Players in Japan
    • 8.3 Japan Fragment-based Drug Discovery Market Size by Type
    • 8.4 Japan Fragment-based Drug Discovery Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Fragment-based Drug Discovery Market Size (2014-2019)
    • 9.2 Fragment-based Drug Discovery Key Players in Southeast Asia
    • 9.3 Southeast Asia Fragment-based Drug Discovery Market Size by Type
    • 9.4 Southeast Asia Fragment-based Drug Discovery Market Size by Application

    10 India

    • 10.1 India Fragment-based Drug Discovery Market Size (2014-2019)
    • 10.2 Fragment-based Drug Discovery Key Players in India
    • 10.3 India Fragment-based Drug Discovery Market Size by Type
    • 10.4 India Fragment-based Drug Discovery Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Fragment-based Drug Discovery Market Size (2014-2019)
    • 11.2 Fragment-based Drug Discovery Key Players in Central & South America
    • 11.3 Central & South America Fragment-based Drug Discovery Market Size by Type
    • 11.4 Central & South America Fragment-based Drug Discovery Market Size by Application

    12 International Players Profiles

    • 12.1 Astex Pharmaceuticals
      • 12.1.1 Astex Pharmaceuticals Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Fragment-based Drug Discovery Introduction
      • 12.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2014-2019)
      • 12.1.5 Astex Pharmaceuticals Recent Development
    • 12.2 Alveus Pharmaceuticals
      • 12.2.1 Alveus Pharmaceuticals Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Fragment-based Drug Discovery Introduction
      • 12.2.4 Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2014-2019)
      • 12.2.5 Alveus Pharmaceuticals Recent Development
    • 12.3 Beactica
      • 12.3.1 Beactica Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Fragment-based Drug Discovery Introduction
      • 12.3.4 Beactica Revenue in Fragment-based Drug Discovery Business (2014-2019)
      • 12.3.5 Beactica Recent Development
    • 12.4 Charles River Laboratories
      • 12.4.1 Charles River Laboratories Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Fragment-based Drug Discovery Introduction
      • 12.4.4 Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2014-2019)
      • 12.4.5 Charles River Laboratories Recent Development
    • 12.5 Crown Bioscience
      • 12.5.1 Crown Bioscience Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Fragment-based Drug Discovery Introduction
      • 12.5.4 Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2014-2019)
      • 12.5.5 Crown Bioscience Recent Development
    • 12.6 Emerald BioStructures
      • 12.6.1 Emerald BioStructures Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Fragment-based Drug Discovery Introduction
      • 12.6.4 Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2014-2019)
      • 12.6.5 Emerald BioStructures Recent Development
    • 12.7 Evotec
      • 12.7.1 Evotec Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Fragment-based Drug Discovery Introduction
      • 12.7.4 Evotec Revenue in Fragment-based Drug Discovery Business (2014-2019)
      • 12.7.5 Evotec Recent Development
    • 12.8 Kinetic Discovery
      • 12.8.1 Kinetic Discovery Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Fragment-based Drug Discovery Introduction
      • 12.8.4 Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2014-2019)
      • 12.8.5 Kinetic Discovery Recent Development
    • 12.9 Proteros Fragments
      • 12.9.1 Proteros Fragments Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Fragment-based Drug Discovery Introduction
      • 12.9.4 Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2014-2019)
      • 12.9.5 Proteros Fragments Recent Development
    • 12.10 Sprint Bioscience
      • 12.10.1 Sprint Bioscience Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Fragment-based Drug Discovery Introduction
      • 12.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2014-2019)
      • 12.10.5 Sprint Bioscience Recent Development
    • 12.11 Structure Based Design
    • 12.12 Sygnature Discovery

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
      In 2018, the global Fragment-based Drug Discovery market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Fragment-based Drug Discovery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fragment-based Drug Discovery development in United States, Europe and China.

      The key players covered in this study
      Astex Pharmaceuticals
      Alveus Pharmaceuticals
      Beactica
      Charles River Laboratories
      Crown Bioscience
      Emerald BioStructures
      Evotec
      Kinetic Discovery
      Proteros Fragments
      Sprint Bioscience
      Structure Based Design
      Sygnature Discovery

      Market segment by Type, the product can be split into
      Fragment Screening
      Fragment Optimization

      Market segment by Application, split into
      Biopharmaceutical Companies
      CROs
      Academic and Research Institutions

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Fragment-based Drug Discovery status, future forecast, growth opportunity, key market and key players.
      To present the Fragment-based Drug Discovery development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Fragment-based Drug Discovery are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now